ADAPTIMMUNE THERAPEUTICS PLC

Ticker: ADAPY CUSIP: 00653A107 Class: SPONDS ADS

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 529,123 Value ($000) $286 Avg Close Range
Q3 2024
Shares 522,608 Value ($000) $496 Avg Close Range
Q2 2024
Shares 144,880 Value ($000) $141 Avg Close Range
Q1 2024
Shares 254,013 Value ($000) $401 Avg Close Range
Q2 2023
Shares 272,681 Value ($000) $254 Avg Close Range
Q4 2022
Shares 89,171 Value ($000) $130 Avg Close Range
Q4 2021
Shares 567,796 Value ($000) $2,130 Avg Close Range
Q3 2021
Shares 1,553,800 Value ($000) $8,033 Avg Close Range
Q2 2020
Shares 376,340 Value ($000) $3,768 Avg Close Range
Q4 2019
Shares 29,102 Value ($000) $35 Avg Close Range
Q3 2019
Shares 79,248 Value ($000) $120 Avg Close Range
Q4 2018
Shares 130,050 Value ($000) $748 Avg Close Range
Q4 2015
Shares 140,983 Value ($000) $1,700 Avg Close Range